Skip to content
PsychoGenics Transforming CNS discovery
Solutions
Therapeutic Areas
Sleep & Seizure Disorders
Mental Illnesses
Neurodegenerative Disorders
Neurodevelopmental Disorders
Neuromuscular Disorders
Pain Disorders
Rare CNS Disorders
Traumatic Brain Injury & Spinal Cord Injury
Preclinical CNS Services
Behavioral and
In Vivo
Testing
Drug Abuse Liability
EEG Studies
Electrophysiology
Preclinical
Ex Vivo
Sample Biomarker Analysis Services
Immunohistochemistry (IHC) & Histology Services
Microdialysis
Pharmacokinetic & Pharmacodynamic (PK/PD) Services
Receptor Occupancy
In Vivo
AI Platforms
eCube™
NeuroCube®
PhenoCube®
SmartCube®
Emerging Therapies
Cell and Gene Therapies
Microbiome
Psychedelics
About
Our Team
Culture
News
Events
Careers
Our Research
Disease Foundations
Contact Us
Open Search
Search
Solutions
Therapeutic Areas
Sleep & Seizure Disorders
Mental Illnesses
Neurodegenerative Disorders
Neurodevelopmental Disorders
Neuromuscular Disorders
Pain Disorders
Rare CNS Disorders
Traumatic Brain Injury & Spinal Cord Injury
Preclinical CNS Services
Behavioral and
In Vivo
Testing
Drug Abuse Liability
EEG Studies
Electrophysiology
Preclinical
Ex Vivo
Sample Biomarker Analysis Services
Immunohistochemistry (IHC) & Histology Services
Microdialysis
Pharmacokinetic & Pharmacodynamic (PK/PD) Services
Receptor Occupancy
In Vivo
AI Platforms
eCube™
NeuroCube®
PhenoCube®
SmartCube®
Emerging Therapies
Cell and Gene Therapies
Microbiome
Psychedelics
About
Our Team
Culture
News
Events
Careers
Our Research
Disease Foundations
Contact Us
Close Menu
Publication
Resources
Changing Drug Discovery for Neuropsychiatric Disorders with Phenotypic Screens
Resources
“Why the TAAR1 agonist ulotaront holds promise for schizophrenia
Resources
Beyond Biotech podcast 23: World Antimicrobial Awareness Week, PsychoGenics
Resources
Harnessing the Power of AI Technology for Drug Discovery Treatments
Resources
A Novel Phenotypic Approach to CNS Drug Discovery
Resources
What will the 2023 drug discovery landscape look like?
Resources
Executives Shares 7 Life Sciences Predictions to Watch in 2023
Resources
The next generation of antidepressants and antipsychotics
Resources
2023 Pharma Predictions
Resources
PsychoGenics CEO explores CNS drug development trends
Posts navigation
Previous
1
2
3
…
16
Next
Partner with us and transform your program
DISCOVER YOUR NEXT BREAKTHROUGH WITH PSYCHOGENICS
Get Started